Rebalix
Logo iSharesiShares · sheet of 5 September 2026
ETF sheet · official issuer and register data

iShares Core MSCI Europe UCITS ETF

CEBZ · IE000MAO75G5 · EUR · domicile Ireland
Equity · Europe · Large & mid capSFDR art. 6
Index tracked: MSCI Europe Index
TER
0.12%+ trans. 0.01%
Fund size
1.2 bn EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.01%
Replication
Physical (optimised)
Income
Accumulating
Launch 20 Mar 2024 · costs from the KID as of 2 Sept 2026 · 387 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Share Class is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the return of the MSCI Europe Index, the Fund’s benchmark index (Index). The Share Class, via the Fund is passively managed and aims to invest so far as possible and practicable in the equity securities (e.g. shares) that make up the Index. The Index measures the performance of listed equity securities of large and mid capitalisation companies in developed equity markets in…

Performance since series start (in euro) — base 100

20 Mar 202431 Aug 2026 · dividends reinvested where declared by the issuer
2025202614096138
High 140 (10 Aug 2026) · low 96 (9 Apr 2025) · last 138. Past performance is not indicative of future results.

Returns in euro

1 year+21.5%
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+38.4%

Risk · 1 / 3 / 5 years

Volatility (ann.)12.02%12.02%
Max drawdown−9.39%−9.39%
Sharpe1.501.50
Sortino2.322.32
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · CEBZ · IE000MAO75G51
RebalixCEBZ · IE000MAO75G5 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+19.67%+19.38%+0.29%

Holdings

Portfolio as declared by the issuer · 31 Aug 2026 · 387 securities · top-10 weight = 21.0%
Top holdingsWeight
ASML HOLDING4.6%
HSBC HOLDINGS PLC2.5%
ROCHE PS PAR AG2.1%
NOVARTIS AG1.9%
SHELL PLC1.8%
NESTLE SA1.8%
ASTRAZENECA PLC1.7%
SIEMENS N AG1.7%
SAP1.6%
BANCO SANTANDER1.5%
Countries (% of fund)
United Kingdom22.4%France15.1%Switzerland14.3%Germany13.8%Netherlands8.7%
Sectors (% of fund)
Financials25.6%Industrials18.7%Health Care12.7%Information Technology9.0%Consumer Staples8.3%

Listing venues

ESMA register (FIRDS) and official exchange lists
CEBZ · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 13 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.blackrock.com/it/investitori-privati/literature/kiid/eu-priips-ish
Factsheet · www.ishares.com/gls-download/literature/fact-sheet/cebz-ishares-core-m
Prospectus · www.blackrock.com/it/investitori-privati/literature/prospectus/ishares
The live sheet, always up to date
rebalix.com/en/etf/IE000MAO75G5
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · CEBZ · IE000MAO75G52